Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingyi Liu

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 27, 2024
Stereotactic radiotherapy vs whole brain radiation therapy in EGFR mutated NSCLC: Results & reflections from the prematurely closed phase III HYBRID trialMing Zeng, Vivek Verma, Xue Chen, et al.
International Journal of Biological Sciences|July 7, 2023
Erratum: A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma: ErratumYingyi Liu, Ye Yao, Bo Liao, et al.
International Journal of Biological Sciences|July 18, 2022
A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinomaYingyi Liu, Ye Yao, Bo Liao, et al.
Dermatology and Therapy|August 7, 2024
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic DermatitisAndrew Blauvelt, Kilian Eyerich, Alan D Irvine, et al.
BMC Cancer|July 15, 2020
Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysisYuemei Sun, Mengwan Wu, Mingxiu Zhou, et al.
Metabolism: Clinical and Experimental|April 15, 2025
ADH1C maintains the homeostasis of metabolic microenvironment to inhibit steatotic hepatocellular carcinomaKequan Xu, Tiangen Wu, Xiaomian Li, et al.
Dermatology and Therapy|May 2, 2024
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)Eric L Simpson, Vimal H Prajapati, Yael A Leshem, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 27, 2024
Stereotactic radiotherapy vs whole brain radiation therapy in EGFR mutated NSCLC: Results & reflections from the prematurely closed phase III HYBRID trialMing Zeng, Vivek Verma, Xue Chen, et al.
International Journal of Biological Sciences|July 7, 2023
Erratum: A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinoma: ErratumYingyi Liu, Ye Yao, Bo Liao, et al.
International Journal of Biological Sciences|July 18, 2022
A positive feedback loop of CENPU/E2F6/E2F1 facilitates proliferation and metastasis via ubiquitination of E2F6 in hepatocellular carcinomaYingyi Liu, Ye Yao, Bo Liao, et al.
Dermatology and Therapy|August 7, 2024
More Time Spent with Clear Skin and No Itch with Upadacitinib versus Dupilumab for Atopic DermatitisAndrew Blauvelt, Kilian Eyerich, Alan D Irvine, et al.
BMC Cancer|July 15, 2020
Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysisYuemei Sun, Mengwan Wu, Mingxiu Zhou, et al.
Metabolism: Clinical and Experimental|April 15, 2025
ADH1C maintains the homeostasis of metabolic microenvironment to inhibit steatotic hepatocellular carcinomaKequan Xu, Tiangen Wu, Xiaomian Li, et al.
Dermatology and Therapy|May 2, 2024
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2)Eric L Simpson, Vimal H Prajapati, Yael A Leshem, et al.
Pageof 10